- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.71 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x YT7: Roluperidone(Non-covalent)
- 12 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.2: 9 residues within 4Å:- Chain A: F.82, F.86, P.105, I.108, Y.109, H.112
- Chain B: M.114, T.115, I.118
8 PLIP interactions:6 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.82, A:F.86, A:P.105, A:I.108, A:Y.109, A:H.112, B:M.114, B:I.118
OLC.3: 3 residues within 4Å:- Chain A: S.122, F.157
- Ligands: OLC.5
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.157
OLC.4: 8 residues within 4Å:- Chain A: A.70, S.74, F.77, F.82
- Chain B: S.122, L.126, D.127
- Ligands: OLC.10
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:A.70, A:F.77, A:F.77, A:F.82, B:L.126
OLC.5: 8 residues within 4Å:- Chain A: I.118, S.122, L.126
- Chain B: A.70, K.73, S.74, F.77
- Ligands: OLC.3
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:A.70, B:F.77, A:I.118, A:L.126, A:L.126
OLC.7: 2 residues within 4Å:- Chain B: L.147, F.148
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.147
OLC.8: 5 residues within 4Å:- Chain B: F.82, P.85, F.86, I.89
- Ligands: OLC.14
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:P.85, B:F.86, B:I.89
OLC.9: 4 residues within 4Å:- Chain B: P.29, I.30, L.33, M.34
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:P.29, B:I.30, B:L.33
OLC.10: 3 residues within 4Å:- Chain B: S.122, L.125
- Ligands: OLC.4
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.125
OLC.11: 3 residues within 4Å:- Chain B: L.125, F.143, R.146
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:L.125, B:L.125, B:F.143, B:F.143
OLC.12: 4 residues within 4Å:- Chain B: T.9, I.162, L.165, F.166
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.162, B:L.165, B:F.166
OLC.13: 9 residues within 4Å:- Chain B: L.32, L.33, L.40, L.44, Y.45, P.46, L.80, V.81, P.85
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:L.32, B:L.33, B:L.40, B:Y.45, B:P.46, B:L.80, B:P.85
OLC.14: 9 residues within 4Å:- Chain A: M.114, V.168
- Chain B: F.82, F.86, P.105, I.108, Y.109, H.112
- Ligands: OLC.8
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:F.82, B:F.86, B:F.86, B:I.108, B:H.112, A:V.168
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alon, A. et al., Structures of the sigma 2 receptor enable docking for bioactive ligand discovery. Nature (2021)
- Release Date
- 2021-12-15
- Peptides
- Sigma intracellular receptor 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.71 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x YT7: Roluperidone(Non-covalent)
- 12 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alon, A. et al., Structures of the sigma 2 receptor enable docking for bioactive ligand discovery. Nature (2021)
- Release Date
- 2021-12-15
- Peptides
- Sigma intracellular receptor 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.